These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 6926784)

  • 1. Adverse effects of antituberculosis drugs causing changes in treatment.
    Gonzalez Montaner LJ; Dambrosi A; Manassero M; Dambrosi VM
    Tubercle; 1982 Dec; 63(4):291-4. PubMed ID: 6926784
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Directly observed treatment for tuberculosis in a Buenos Aires City hospital].
    González C; Sáenz C; Herrmann E; Jajati M; Kaplan P; Monzón D
    Medicina (B Aires); 2012; 72(5):371-9. PubMed ID: 23089112
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Side effects of various combinations of rifampin and isoniazid with ethambutol or streptomycin and pyrazinamide in short-term chemotherapy of newly-detected pulmonary tuberculosis].
    Zierski M; Bek E
    Pneumonol Pol; 1980 Jul; 48(7):469-79. PubMed ID: 7433146
    [No Abstract]   [Full Text] [Related]  

  • 4. Risk factors for side-effects of isoniazid, rifampin and pyrazinamide in patients hospitalized for pulmonary tuberculosis.
    Schaberg T; Rebhan K; Lode H
    Eur Respir J; 1996 Oct; 9(10):2026-30. PubMed ID: 8902462
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antituberculous therapy and acute liver function.
    Ong EL
    Lancet; 1995 May; 345(8958):1171. PubMed ID: 7723557
    [No Abstract]   [Full Text] [Related]  

  • 6. [Comparative evaluation of several functional tests of the liver in patients with pulmonary tuberculosis with side-reactions to tuberculostatic preparations].
    Kaminskaia GO; Karachunskiĭ MA; Kolosovskaia VP
    Ter Arkh; 1969 Nov; 41(11):75-9. PubMed ID: 5384752
    [No Abstract]   [Full Text] [Related]  

  • 7. Side effects of drugs used to treat tuberculosis.
    Newton RW
    Scott Med J; 1975 Mar; 20(2):47-9. PubMed ID: 47648
    [No Abstract]   [Full Text] [Related]  

  • 8. Adverse reactions to drugs used in the treatment of tuberculosis.
    Nariman S
    Adverse Drug React Acute Poisoning Rev; 1988; 7(4):207-27. PubMed ID: 3071113
    [No Abstract]   [Full Text] [Related]  

  • 9. A case of thrombocytopenia caused by rifampicin and pyrazinamide.
    Bansal R; Sharma PK; Sharma A
    Indian J Pharmacol; 2013; 45(4):405-7. PubMed ID: 24014922
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Drug reactions. 18. Cutaneous reactions to antituberculous drugs.
    Levantine A; Almeyda J
    Br J Dermatol; 1972 Jun; 86(6):651-5. PubMed ID: 4114691
    [No Abstract]   [Full Text] [Related]  

  • 11. Adverse reactions to short-course regimens containing streptomycin, isoniazid, pyrazinamide and rifampicin in Hong Kong.
    Tubercle; 1976 Jun; 57(2):81-95. PubMed ID: 134476
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Hepatic functional changes induced by the combined use of isoniazid, pyrazinamide and rifampicin in the treatment of pulmonary tuberculosis].
    de Souza AF; de Oliveira e Silva A; Baldi J; de Souza TN; Rizzo PM
    Arq Gastroenterol; 1996; 33(4):194-200. PubMed ID: 9302332
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adverse effects of antituberculosis drugs.
    Girling DJ
    Drugs; 1982; 23(1-2):56-74. PubMed ID: 6459920
    [No Abstract]   [Full Text] [Related]  

  • 14. Clinical trial of six-month and four-month regimens of chemotherapy in the treatment of pulmonary tuberculosis.
    Am Rev Respir Dis; 1979 Apr; 119(4):579-85. PubMed ID: 375787
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Olfactory disturbance related to pyrazinamide.
    Tsou CC; Chien JY
    QJM; 2014 Mar; 107(3):217-8. PubMed ID: 24023071
    [No Abstract]   [Full Text] [Related]  

  • 16. Chromosomal aberrations in tuberculosis patients before and after treatment with short-term chemotherapy.
    Rac VV; Gupta EV; Thomas IM
    Mutat Res; 1991 Jan; 259(1):13-9. PubMed ID: 1988820
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antituberculous therapy and acute liver function.
    Bourke SJ; White J; Stenton SC; Hendrick DJ
    Lancet; 1995 May; 345(8958):1171-2. PubMed ID: 7786347
    [No Abstract]   [Full Text] [Related]  

  • 18. Assessment of a combined preparation of isoniazid, rifampicin and pyrazinamide (Rifater) in the initial phase of chemotherapy in three 6-month regimens for smear-positive pulmonary tuberculosis: a five-year follow-up report.
    Teo SK
    Int J Tuberc Lung Dis; 1999 Feb; 3(2):126-32. PubMed ID: 10091877
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Therapy of tuberculosis in the adult].
    Schrappe M; Wassermann K; Kroegel C
    Med Klin (Munich); 1995 Apr; 90(4):229-30. PubMed ID: 7776936
    [No Abstract]   [Full Text] [Related]  

  • 20. [Effectiveness and problems of PZA-containing 6-month regimen for the treatment of new pulmonary tuberculosis patients].
    Wada M
    Kekkaku; 2001 Jan; 76(1):33-43. PubMed ID: 11211781
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.